We are live on
!
Find out more
MCP
Mirador Capital Partners Portfolio holdings
AUM
$817M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.46%
3 Year Est. Return
+102.43%
5 Year Est. Return
+126.93%
10 Year Est. Return
+392.96%
AUM
$571M
AUM Growth
+$19.1M
(+3.5%)
Cap. Flow
+$41.4M
Cap. Flow
% of AUM
7.25%
Top 10 Holdings %
Top 10 Hldgs %
42.03%
Holding
213
New
17
Increased
128
Reduced
40
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Short S&P500
SH
|
+$7.3M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$4.42M |
| 3 |
Chubb
CB
|
+$3.7M |
| 4 |
Zillow
Z
|
+$3.67M |
| 5 |
Goldman Sachs
GS
|
+$3.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$6.46M |
| 2 |
BSJP
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
|
+$4.87M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.48M |
| 4 |
Constellation Brands
STZ
|
+$1.24M |
| 5 |
Visa
V
|
+$882K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Financials | 17.41% |
| 3 | Healthcare | 10.45% |
| 4 | Communication Services | 8.15% |
| 5 | Consumer Discretionary | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Coya Therapeutics
COYA
$111M
| – | – |
-13,807
| Closed | -$79.1K |
|
202
CRISPR Therapeutics
CRSP
$5.17B
| – | – |
-7,536
| Closed | -$297K |
|
203
Walt Disney
DIS
$179B
| – | – |
-2,155
| Closed | -$240K |
|
204
Las Vegas Sands
LVS
$29.7B
| – | – |
-6,487
| Closed | -$333K |
|
205
MGM Resorts International
MGM
$11B
| – | – |
-5,872
| Closed | -$203K |
|
206
The Mosaic Company
MOS
$7.41B
| – | – |
-9,548
| Closed | -$235K |
|
207
Newmont
NEM
$123B
| – | – |
-7,126
| Closed | -$265K |
|
208
Invesco Dorsey Wright Momentum ETF
PDP
$1.49B
| – | – |
-2,000
| Closed | -$215K |
|
209
Parker-Hannifin
PH
$135B
| – | – |
-620
| Closed | -$394K |
|
210
SoFi Technologies
SOFI
$23.1B
| – | – |
-18,601
| Closed | -$286K |
|
|
211
Constellation Brands
STZ
$22.7B
| – | – |
-5,610
| Closed | -$1.24M |
|
212
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-3,477
| Closed | -$313K |
|
|
EDR
213
DELISTED
Endeavor Group Holdings, Inc.
EDR
| – | – |
-27,057
| Closed | -$847K |
|
Similar funds
BC
KCP
ACM
AR
DI
AC
CCM
VT
Mirador Capital Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Mirador Capital Partners held 213 positions worth $571M, up 3.5% from $552M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Mirador Capital Partners deployed $41.4M of net new capital in Q1 2025, opening 17 new positions and adding to 128 existing holdings. Its largest new stake was Goldman Sachs: 6,053 shares worth $3.31M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $6.46M trimmed.
- Mirador Capital Partners's largest Q1 2025 buy was Goldman Sachs: 6,053 shares worth $3.31M.
- Mirador Capital Partners added most to ProShares Short S&P500 in Q1 2025, an estimated $7.3M increase.
- Mirador Capital Partners's biggest Q1 2025 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $6.46M.
- Mirador Capital Partners fully exited Constellation Brands in Q1 2025, selling an estimated $1.24M.
- Mirador Capital Partners's ten largest holdings make up 42% of its $571M portfolio in Q1 2025.
- Mirador Capital Partners opened 17 new positions and closed 16 in Q1 2025.
- Mirador Capital Partners's portfolio value rose 3.5% quarter-over-quarter to $571M.
Based on Mirador Capital Partners's 13F filing for Q1 2025, filed 9 Apr 2025.